| Announce Date | 05/09/2025 |
| EPS Normalized Actual | $-0.15 (Miss by $-0.09) |
| EPS GAAP Actual | $-0.15 (Miss by $-0.09) |
| Revenue Actual | $0.029366B |
| Revenue Surprise | Beat by $29.366M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.047516 |
| EPS GAAP Estimate | $0.047516 |
| Revenue Estimate | $0.051934B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.0436 | 45.18 | 0.0436 | 0.0436 | 1 |
| Dec 2025 | -0.24202 | -8.14 | -0.24202 | -0.24202 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -0.15 | -0.15 | 0.029366B | 100% | 29.37M |
| FQ4 2024 (Dec 2024) | -0.091 | -0.091 | 0.031689B | 100% | 31.69M |
| FQ3 2024 (Sep 2024) | 0.0458 | 0.0458 | 0.037098B | 100% | 37.1M |
| FQ2 2024 (Jun 2024) | -0.0381 | -0.0381 | 0.03556B | 100% | 35.56M |
| FQ1 2013 (Mar 2013) | 0.0687 | 0.0687 | 0.00691367B | 100% | 6.91M |
| FQ2 2013 (Jun 2013) | 0.0688 | 0.0688 | 0.00691998B | 100% | 6.92M |
| FQ3 2013 (Sep 2013) | -0.0793 | -0.0793 | 0.00255646B | 100% | 2.56M |
| FQ4 2013 (Dec 2013) | -0.0811 | -0.0811 | 0.00261575B | 100% | 2.62M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.047516
Consensus Revenue Estimates
0.051934B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.006826 | -- | -0.006826 | -0.006826 | 1 |
| FQ3 2027 (Sep 2027) | 0.051096 | -- | 0.051096 | 0.051096 | 1 |
| FQ2 2027 (Jun 2027) | -0.003092 | -- | -0.003092 | -0.003092 | 1 |
| FQ1 2027 (Mar 2027) | -0.044785 | -- | -0.044785 | -0.044785 | 1 |
| FQ4 2026 (Oct 2026) | -0.02225 | -- | -0.02225 | -0.02225 | 0 |
| FQ3 2026 (Jul 2026) | 0.042924 | -- | 0.042924 | 0.042924 | 0 |
| FQ2 2026 (Jun 2026) | 0.042924 | -- | 0.042924 | 0.042924 | 0 |
| FQ1 2026 (Mar 2026) | 0.047516 | 415.68 | 0.047516 | 0.047516 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ3 2027 (Sep 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ2 2027 (Jun 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ1 2027 (Mar 2027) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ4 2026 (Oct 2026) | 0.05B | -- | 0.05B | 0.05B | 0 |
| FQ3 2026 (Jul 2026) | 0.05B | -- | 0.05B | 0.05B | 0 |
| FQ2 2026 (Jun 2026) | 0.05B | -- | 0.05B | 0.05B | 0 |
| FQ1 2026 (Mar 2026) | 0.05B | 43.46 | 0.05B | 0.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -0.15 | -0.15 | 100% | |
| FQ4 2024 (Dec 2024) | -0.091 | -0.091 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0458 | 0.0458 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0381 | -0.0381 | 100% | |
| FQ1 2013 (Mar 2013) | 0.0687 | 0.0687 | 100% | |
| FQ2 2013 (Jun 2013) | 0.0688 | 0.0688 | 100% | |
| FQ3 2013 (Sep 2013) | -0.0793 | -0.0793 | 100% | |
| FQ4 2013 (Dec 2013) | -0.0811 | -0.0811 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0B | $0.03B | $29.37M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.03B | $31.69M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.04B | $37.1M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.04B | $35.56M | 100% |
| FQ1 2013 (Mar 2013) | $0B | $0.01B | $6.91M | 100% |
| FQ2 2013 (Jun 2013) | $0B | $0.01B | $6.92M | 100% |
| FQ3 2013 (Sep 2013) | $0B | $0B | $2.56M | 100% |
| FQ4 2013 (Dec 2013) | $0B | $0B | $2.62M | 100% |